ATNM

Company Update (NYSE:ATNM): Actinium Pharmaceuticals Inc Announces Iomab-B IND Has Been Cleared By FDA

Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers.

Corey Williams — December 17, 2015, 8:22 AM EDT

Stock Update (NYSE MKT:ATNM): Actinium Pharmaceuticals Inc Files Orphan Drug Application for Use of Iomab-B in Treating Refractory and Relapsed Acute Myeloid Leukemia in Elderly Patients

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that …

Corey Williams — November 23, 2015, 8:43 AM EDT

Company Update (NYSE:ATNM): Anthem Inc Submits Iomab-B IND Application to the U.S. FDA

Anthem Inc (NYSE:ANTM), is a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that it …

Corey Williams — November 17, 2015, 6:16 PM EDT

Stock Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Completion of the Fourth and Final Cohort of its Actimab-A Trial

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), is a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today that …

Corey Williams — October 15, 2015, 8:16 AM EDT

Stock Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Futher Strengthens Team Adding An Accomplished Finance and Corporate Development Professional

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) is a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers. Actinium announced today the …

Corey Williams — October 13, 2015, 9:11 AM EDT

Stock Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Successfully Labels Antibody with Actinium-225 For Next Entry into Pipeline

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM) successfully completed foundational phases of development of an antibody construct labeled with actinium-225 using the Company’s novel proprietary APIT …

Corey Williams — August 10, 2015, 7:42 AM EDT

Company Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Issues Letter to Shareholders Outlining Measures to Move Iomab-B and Actimab-A Into Advanced Development

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it has …

Corey Williams — August 5, 2015, 3:03 PM EDT

Stock Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Announces $5 Million Registered Direct Offering of Common Stock

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that it entered …

Corey Williams — June 4, 2015, 2:48 PM EDT

Company Update (NYSE MKT:ATNM): Actinium Pharmaceuticals Inc’s Clinical Data Generate Significant Interest at 2015 ASCO Annual Meeting

Actinium Pharmaceuticals Inc (NYSE MKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that the presentation …

Corey Williams — June 4, 2015, 8:35 AM EDT

Stock Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Clinical Update on Actimab-A Provided at Targeted Alpha Therapy Symposium

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, recently sponsored the 9 th …

Corey Williams — May 29, 2015, 2:49 PM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts